Cancer is a fascinating but rapidly evolving discipline - it's a full-time job just keeping up to date. In this podcast, Dr Michael Fernando and Dr Joshua Hurwitz explore the latest trials, research, and practice-changing updates, as well as regular interviews with renowned oncology specialists. Ideal for those starting their training journey, established specialists and anyone interested in medical science, oncological practice, or terrible jokes. Preferably all three.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>

Oncology for the Inquisitive Mind
Claim This Podcastby Michael Fernando and Josh Hurwitz
Podcast Authority
Beta
Podcast Overview
Cancer is a fascinating but rapidly evolving discipline - it's a full-time job just keeping up to date. In this podcast, Dr Michael Fernando and Dr Joshua Hurwitz explore the latest trials, research, and practice-changing updates, as well as regular interviews with renowned oncology specialists. Ideal for those starting their training journey, established specialists and anyone interested in medical science, oncological practice, or terrible jokes. Preferably all three.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
7/31/2022
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Oncology for the Inquisitive Mind
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

May 31, 2026
203. Back to Basics - Early Pancreatic Cancer
<p>This week, we take a "back to the future" look at the early-stage pancreatic cancer phase, a relatively stagnant area in terms of pivotal trials. The two trials are the ESPAC4 trial, which examines doublet chemotherapy in pancreatic cancer, and Josh does a traditional deep dive into the world of neoadjuvant chemotherapy. He highlights ESPAC-5, PREOPANC-2, and the TAPS consortium, to name a few. A complicated but overall evolving field.</p><br><p><strong>Studies discussed in this episode:</strong></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/28129987/" rel="noopener noreferrer" target="_blank">ESPAC-4</a></p><p><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3958454/" rel="noopener noreferrer" target="_blank">FOLFOXIRI</a></p><p><a href="https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00363-8/abstract" rel="noopener noreferrer" target="_blank">PREOPANC-2</a></p><p><a href="https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00348-X/fulltext" rel="noopener noreferrer" target="_blank">ESPAC-5</a></p><p><a href="https://www.hpbonline.org/article/S1365-182X(22)00223-4/fulltext" rel="noopener noreferrer" target="_blank">TAPS</a> (Trans-Atlantic Pancreatic Surgery (TAPS) Consortium Study)</p><br><p>For more episodes, resources and blog posts, visit <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/www.inquisitiveonc.com" rel="noopener noreferrer" target="_blank">www.inquisitiveonc.com</a></p><p>Please find us on Twitter <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/@InquisitiveOnc!" rel="noopener noreferrer" target="_blank">@InquisitiveOnc!</a></p><p>If you want us to look at a specific trial or subject, email us at <a href="mailto:inquisitiveonc@gmail.com" rel="noopener noreferrer" target="_blank">inquisitiveonc@gmail.com</a></p><br><p>Art courtesy of Taryn Silver</p><p>Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/</p><br><p>Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.</p><br><p>Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>

May 24, 2026
202. Back to Basics - Advanced Pancreatic Cancer
<p>Today, we accidentally skipped early pancreatic cancer and jumped straight to advanced pancreatic cancer. It was a sombre episode, with clinicians and advocates screaming for better treatment options for this cancer. While small incremental advances have been made, the holy grail remains elusive.</p><br><p>Today our focus is on NAPOLI-3, the use of liposomal irinotecan (NALIRIFOX), and PANOVA-3, where TTFields are used in combination with gemcitabine/abraxane. A good conversation, though the current premise is sad. Hopefully, as time moves on, this conversation will be more optimistic. </p><br><p><strong>Studies discussed in this episode:</strong></p><p><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01366-1/fulltext" rel="noopener noreferrer" target="_blank">NAPOLI-3</a></p><p><a href="https://ascopubs.org/doi/10.1200/JCO-25-00746" rel="noopener noreferrer" target="_blank">PANOVA-3</a></p><br><p>For more episodes, resources and blog posts, visit <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/www.inquisitiveonc.com" rel="noopener noreferrer" target="_blank">www.inquisitiveonc.com</a></p><p>Please find us on Twitter <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/@InquisitiveOnc!" rel="noopener noreferrer" target="_blank">@InquisitiveOnc!</a></p><p>If you want us to look at a specific trial or subject, email us at <a href="mailto:inquisitiveonc@gmail.com" rel="noopener noreferrer" target="_blank">inquisitiveonc@gmail.com</a></p><br><p>Art courtesy of Taryn Silver</p><p>Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/</p><br><p>Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.</p><br><p>Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>

May 17, 2026
201. Back to Basics - Advanced Gastric/GOJ Cancer
<p>On today's episode, Josh and Michael "advance" in their ongoing GI journey, as Michael continuously insists on saying, to discuss advanced gastric and GOJ cancer. Historically, an orphan disease with a very poor prognosis, perhaps the first rays of light are beginning to shine on this difficult-to-treat cancer type. Immunotherapy has been well established as standard of care, but are there any new agents that are emerging in this space? As always, the answer to that question is "yes," and as usual, the agent in question is trastuzumab deruxtecan. Listen on for all the surprising details, even more awful puns, and a strange tangent about the difference between a "good" and "effective" dictator.</p><br><p><strong>Studies discussed in this episode:</strong></p><p><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2111380" rel="noopener noreferrer" target="_blank">Checkmate 648</a>/<a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00797-2/fulltext" rel="noopener noreferrer" target="_blank">649</a></p><p><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2004413" rel="noopener noreferrer" target="_blank">Destiny-Gastric01</a></p><br><p>For more episodes, resources and blog posts, visit <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/www.inquisitiveonc.com" rel="noopener noreferrer" target="_blank">www.inquisitiveonc.com</a></p><p>Please find us on Twitter <a href="https://open.acast.com/networks/62d20dbcffef490011c8df4d/shows/62d20dbcffef490011c8df4b/episodes/@InquisitiveOnc!" rel="noopener noreferrer" target="_blank">@InquisitiveOnc!</a></p><p>If you want us to look at a specific trial or subject, email us at <a href="mailto:inquisitiveonc@gmail.com" rel="noopener noreferrer" target="_blank">inquisitiveonc@gmail.com</a></p><br><p>Art courtesy of Taryn Silver</p><p>Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/</p><br><p>Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.</p><br><p>Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
221 total episodes available
Recent guests on Oncology for the Inquisitive Mind
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Jeanne Tie
Guest
Dr Belinda Yeo
Guest
Dr James McCracken
Guest
Dr Prachi Bhave
Guest
Dr Janet Abrahm
Guest
Dr Ned McNamee
Guest
Dr Enrique Grande
Guest
Dr Anthony Joshua
Guest
Dr Adam Brufsky
Guest
Similar Podcasts
Discover related shows you might enjoy

Two Onc Docs
Sam and Karine

ASCO Daily News
American Society of Clinical Oncology (ASCO)

The Oncology Podcast
The Oncology Network

The Diary Of A CEO with Steven Bartlett
DOAC

Plenary Session
Vinay Prasad, MD MPH

The Oncology Nursing Podcast
Oncology Nursing Society

Chanticleer
Australian Financial Review

Australian Prescriber Podcast
Australian Prescriber

Oncology Brothers
Oncology Brothers

ZOE Science & Nutrition
ZOE

TOGA Podcast
Thoracic Oncology Group Of Australasia (TOGA)

ABC News Daily
ABC Australia

Economist Podcasts
The Economist

WorkLife with Adam Grant
TED

JAMA Clinical Reviews
JAMA Network
Deep-dive analytics for Oncology for the Inquisitive Mind
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Oncology for the Inquisitive Mind?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.